Showing results (41-50 of 389) with videos related to
Sort By:
Pageof 39
Urology|November 1, 1996
Constitutive expression of high levels of prostate-specific antigen in the absence of prostate carcinomaA S Kibel, K Krithivas, L B Shamel, et al.Journal of the National Cancer Institute|December 21, 2000
Racial variation in prostate cancer incidence and in hormonal system markers among male health professionalsE A Platz, E B Rimm, W C Willett, et al.Cancer|July 15, 1993
Meningeal carcinomatosis from transitional cell carcinoma of the bladderC Eng, D Cunningham, B J Quade, et al.Radiology|September 1, 1991
CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?P C Stomper, L A Kalish, M B Garnick, et al.The Journal of Urology|May 8, 2000
Comparing prostate specific antigen outcomes after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factorsA V D'Amico, D Schultz, L Schneider, et al.Prostate Cancer and Prostatic Diseases|August 10, 2016
Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancerR R McKay, L Werner, M Fiorillo, et al.Urology|April 11, 2001
Other novel agents: Rationale and current status as chemopreventive agentsA W Tolcher, A Kennedy, R J Padley, et al.Molecular Immunology|December 1, 1994
Structure-function correlates of autoantibodies to nucleic acids. Lessons from immunochemical, genetic and structural studiesD Eilat, W F AndersonActa Crystallographica. Section A, Foundations of Crystallography|May 1, 1988
Application of the molecular replacement method to multidomain proteins. 2. Comparison of various methods for positioning an oriented fragment in the unit cellM Cygler, W F AndersonBio Systems|January 1, 1985
Computer modeling studies of the structure of a repressorW F Anderson, M CyglerPageof 39